ATE194776T1 - Verfahren zur herstellung von lipid-konjugaten - Google Patents

Verfahren zur herstellung von lipid-konjugaten

Info

Publication number
ATE194776T1
ATE194776T1 AT94901260T AT94901260T ATE194776T1 AT E194776 T1 ATE194776 T1 AT E194776T1 AT 94901260 T AT94901260 T AT 94901260T AT 94901260 T AT94901260 T AT 94901260T AT E194776 T1 ATE194776 T1 AT E194776T1
Authority
AT
Austria
Prior art keywords
lipid
biologically active
acetoacetylated
mixed
active agent
Prior art date
Application number
AT94901260T
Other languages
English (en)
Inventor
Barbara Yu-Fong Wan
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE194776T1 publication Critical patent/ATE194776T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/21—Hydrocarbon
    • Y10T436/214—Acyclic [e.g., methane, octane, isoparaffin, etc.]
    • Y10T436/216—Unsaturated [e.g., ethylene, diene, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94901260T 1992-11-05 1993-11-05 Verfahren zur herstellung von lipid-konjugaten ATE194776T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/972,361 US5329029A (en) 1992-11-05 1992-11-05 Phosphatidylalkanolamine derivatives and their use in generating phospholipid conjugates
PCT/US1993/010601 WO1994009827A1 (en) 1992-11-05 1993-11-05 Process for making lipid conjugates

Publications (1)

Publication Number Publication Date
ATE194776T1 true ATE194776T1 (de) 2000-08-15

Family

ID=25519564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94901260T ATE194776T1 (de) 1992-11-05 1993-11-05 Verfahren zur herstellung von lipid-konjugaten

Country Status (9)

Country Link
US (2) US5329029A (de)
EP (1) EP0666762B1 (de)
AT (1) ATE194776T1 (de)
DE (1) DE69329069T2 (de)
DK (1) DK0666762T3 (de)
ES (1) ES2148310T3 (de)
GR (1) GR3033870T3 (de)
PT (1) PT666762E (de)
WO (1) WO1994009827A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
FR2714830B1 (fr) * 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
AUPM747694A0 (en) * 1994-08-16 1994-09-08 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids and peptides
WO1997020076A1 (en) * 1995-11-29 1997-06-05 Nexstar Pharmaceuticals, Inc. Methods for optimizing multicomponent formulations
AUPN741696A0 (en) * 1996-01-05 1996-01-25 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids ii
EP0784984B1 (de) * 1996-01-17 2003-07-02 F. Hoffmann-La Roche Ag Transfektionskompetente Moleküle
DE69736385T2 (de) * 1996-02-09 2007-08-23 Pi-Wan Cheng Kationisches lipid und rezeptorligand erleichterte gabe von biologisch aktiven molekuelen
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
WO1999015206A1 (en) * 1997-09-23 1999-04-01 Megabios Corporation Methods for preparing lipids/polynucleotide transfection complexes
WO2001060412A2 (en) 2000-02-15 2001-08-23 Genzyme Corporation Modification of biopolymers for improved drug delivery
US6749865B2 (en) * 2000-02-15 2004-06-15 Genzyme Corporation Modification of biopolymers for improved drug delivery
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US20030229013A1 (en) * 2001-12-07 2003-12-11 Shih-Kwang Wu Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
US7299805B2 (en) 2002-06-07 2007-11-27 Marctec, Llc Scaffold and method for implanting cells
WO2008133534A2 (en) * 2007-04-27 2008-11-06 Kode Biotech Limited Carbohydrate-lipid constructs and their use in preventing or treating viral infection
DK1735323T3 (en) 2004-03-22 2017-12-11 Kode Biotech Ltd Synthetic Membrane Anchors
US10858384B2 (en) 2004-03-22 2020-12-08 Kode Biotech Limited Synthetic molecule constructs
US7968124B2 (en) * 2004-07-13 2011-06-28 Lyotropic Therapeutics, Inc. Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
US20090162277A1 (en) * 2005-11-03 2009-06-25 Clemson University Lysophospholipids Solubilized Single-Walled Carbon Nanotubes
US8426152B2 (en) 2007-01-03 2013-04-23 Lamdagen Corporation Enzymatic assay for LSPR
US8105809B2 (en) * 2008-07-03 2012-01-31 Accera, Inc. Enzymatic synthesis of acetoacetate esters and derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645866B1 (fr) * 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1993012240A1 (en) * 1991-12-17 1993-06-24 The Regents Of The University Of California Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)

Also Published As

Publication number Publication date
PT666762E (pt) 2000-12-29
US5329029A (en) 1994-07-12
EP0666762A1 (de) 1995-08-16
EP0666762B1 (de) 2000-07-19
DK0666762T3 (da) 2000-09-18
GR3033870T3 (en) 2000-10-31
US5451661A (en) 1995-09-19
DE69329069T2 (de) 2000-12-21
ES2148310T3 (es) 2000-10-16
WO1994009827A1 (en) 1994-05-11
DE69329069D1 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
ATE194776T1 (de) Verfahren zur herstellung von lipid-konjugaten
PL319833A1 (en) Compounds and composition for carrying active media
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
MY110734A (en) Improvements in or relating to dioic acids.
DE69020422D1 (de) Zusammensetzung in Form eines Schaumes enthaltend 5-Aminosalicylic Säure zur intra-rektal Verabreichung.
ATE218359T1 (de) Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
KR900700089A (ko) 전신성 피부 투과적 투여를 위한 약학적 조성물
IL112880A0 (en) 9-deoxotaxane compounds
CA2146565A1 (en) Compositions for treatment of inflamed tissues
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
CA2203456A1 (en) Topical analgesic composition
DE69724599D1 (de) Zusammensetzung zur zielortspezifischen verabreichung eines medikamentes und verfahren zur anwendung
MY131090A (en) Penetration enhancing substance.
FR2708616B1 (fr) Procédé de préparation d'une composition aqueuse sous forme de gel et compositions susceptibles d'être obtenues par ce procédé, notamment composition contenant des vésicules, en particulier des liposomes.
DK148586A (da) Fremgangsmaade til fremstilling af konjugater af metal-lothionein og biologisk aktive molekyler
ATE168695T1 (de) Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisierten tumorspezifischen enzym- konjugaten
ATE226428T1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
ATE507844T1 (de) Verfahren zur herstellung eines homogenen doxorubicin-transferrin kojugates
NZ332497A (en) Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent
AU7652198A (en) Use of ester quaternaries as emulsifiers for producing preparations for coloring keratin fibers
DE69803772D1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
KR910019605A (ko) 항진균성 겔제
AR003920A1 (es) Metodo para producir complejos droga/lipidos que tienen cargas positivas en exceso con respecto a la droga y los complejos droga/lipidos obtenidos condicho metodo y metodo para dispensar una droga a una persona.
JPH0742213B2 (ja) 毛髪処理剤組成物

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee